Sunshine Lake Pharma Co., Ltd.
Clinical trials sponsored by Sunshine Lake Pharma Co., Ltd., explained in plain language.
Sunshine Lake Pharma is a Chinese pharmaceutical company developing innovative drugs and generics.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Healthy men needed to test new Injection's safety Results expected Sep 2026 (estimated)
- New pill HEC585 aims to slow lung scarring in rare disease Results expected Dec 2026 (estimated)
- New pill targets RET-Driven cancers in early trial Results expected Dec 2026 (estimated)
- Liver health may change how cancer drug works Results expected Dec 2026 (estimated)
- Healthy volunteers needed to test safety of experimental NASH drug Results expected Dec 2026 (estimated)
-
New injectable drug tested against Hard-to-Treat solid tumors
Disease control Not yet recruitingResearchers are running a Phase I trial of HEC-921, an experimental drug given by intravenous infusion, in adults with advanced malignant solid tumors. The study first gives HEC-921 alone to find the highest dose people can tolerate, then tests it in combination with oxaliplatin,…
Phase 1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Liver health may change how cancer drug works
Knowledge-focused Not yet recruitingThis trial investigates how the body handles larotinib, an experimental cancer drug, in people with mild or moderate liver impairment compared to healthy volunteers. Participants receive a single oral dose, and researchers measure drug levels in the blood over time. The goal is t…
Phase 1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Healthy volunteers needed to test clifutinib drug interactions
Knowledge-focused Not yet recruitingThis study looks at how three common drugs (itraconazole, fluconazole, and efavirenz) change the way clifutinib works in the body. It involves 80 healthy adults who will take a single dose of clifutinib along with one of these drugs. The goal is to measure drug levels and check f…
Phase 1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC